| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
National Institute of Arthritis and Metabolic Diseases and National Institute of Mental Health Bethesda, Maryland 20014
Abstract
The effect of various Li+ treatments on the release of 131I in vitro by mouse thyroid glands was studied. Chronic Li+ feeding and acute Li+ injection inhibited both DBCAMP- stimulated release of 131I and TSH-stimulated release of 131I. By use of preincubation with Li+, inhibition of TSH-stimulated 131I release was demonstrated in a completely in vitro system. 131I release and colloid droplets were decreased in parallel. Li+ inhibition of thyroid secretion thus occurs at a step between the generation of intracellular cyclic-AMP and colloid droplet formation. (Endocrinology 88:1385,1971)
Footnotes
1 A preliminary report has been published (J Clin Invest 41: 9a, 1970).
Received December 8, 1970.
This article has been cited by other articles:
![]() |
W. E. Bunney Jr, A. Pert, J. Rosenblatt, C. B. Pert, and D. Gallaper Mode of Action of Lithium: Some Biological Considerations Arch Gen Psychiatry, July 1, 1979; 36(8): 898 - 901. [Abstract] [PDF] |
||||
![]() |
D. McMahon Chemical Messengers in Development: A Hypothesis Science, September 20, 1974; 185(4156): 1012 - 1021. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |